Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Published Online: 2026-02-?
Journal: The Lancet Infectious Diseases•Publisher: Elsevier BV
Authors: Arjen M Dondorp•Attasit Srisubat•Bootsakorn Loharjun•Borimas Hanboonkunupakarn•Elizabeth M Batty•Ellen Beer•James A Watson•Jaruwan Tubprasert•Jindarat Kouhathong•Kanokon Suwannasin•Kesinee Chotivanich•Kittiyod Poovorawan•Koukeo Phommasone•Mallika Imwong•Manus Potaporn•Mohammad Yazid Abdad•Nicholas J White•Nicholas P J Day•Phrutsamon Wongnak•Podjanee Jittamala•Sasithon Pukrittayakamee•Shivani Singh•Simon Boyd•Tanatchakorn Asawasriworanan•Tanaya Siripoon•Terry John Evans•Thatsanun Ngernseng•Thundon Ngamprasertchai•Tianrat Piteekan•Timothy Seers•Varaporn Kruabkontho•Viravarn Luvira•Wanassanan Madmanee•Watcharapong Piyaphanee•Watcharee Pagornrat•Weerapong Phumratanaprapin•William H K Schilling
